ORAMED PHARMACEUTICALS INC. Investment Warrants, Exercise Price
ORAMED PHARMACEUTICALS INC. (ORMP) reported Investment Warrants, Exercise Price of $7.25 for the 12-month period ending 2018-08-31, per its 10-K filed 2018-11-28.
Discontinued › Notes
invest:InvestmentWarrantsExercisePrice · last filed 2018-11-28
- ORAMED PHARMACEUTICALS INC. investment warrants, exercise price for fiscal 2018 was $7.25.
USD
| Period end | Investment Warrants, Exercise Price 0 month | Investment Warrants, Exercise Price 12 month |
|---|---|---|
| 2018-08-31 | $7.25 10-K · filed 2018-11-28 | |
| 2015-06-04 | $10.00 10-K · filed 2016-11-25 |
USD/shares
| Period end | Investment Warrants, Exercise Price 0 month | Investment Warrants, Exercise Price 12 month |
|---|---|---|
| 2018-08-31 | $7.25 10-K · filed 2018-11-28 | |
| 2015-06-04 | $10.00 10-K · filed 2016-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |